NEW BRUNSWICK, NJ: Johnson & Johnson is using its corporate blog and Twitter feed to defend its Tylenol brand to the public, following a recommendation from a Food and Drug Administration (FDA) panel that would reduce acetaminophen dosage.

On June 30, the FDA panel recommended that the maximum daily dose of acetaminophen be lowered and that the amount of the drug in a single over-the-counter (OTC) pill be limited.

J&J posted a blog on JNJ BTW ...